115 related articles for article (PubMed ID: 2387642)
1. Luteinizing hormone pulsatility in men with damage to the germinal epithelium.
Talbot JA; Shalet SM; Tsatsoulis A; Grabinski M; Robertson WR
Int J Androl; 1990 Jun; 13(3):223-31. PubMed ID: 2387642
[TBL] [Abstract][Full Text] [Related]
2. The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
Tsatsoulis A; Whitehead E; St John J; Shalet SM; Robertson WR
Clin Endocrinol (Oxf); 1987 Dec; 27(6):683-9. PubMed ID: 3138051
[TBL] [Abstract][Full Text] [Related]
3. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.
Howell SJ; Radford JA; Ryder WD; Shalet SM
J Clin Oncol; 1999 May; 17(5):1493-8. PubMed ID: 10334536
[TBL] [Abstract][Full Text] [Related]
4. The pulsatile secretion of bioactive luteinising hormone in normal adult men.
Talbot JA; Rodger RS; Shalet SM; Littley MD; Robertson WR
Acta Endocrinol (Copenh); 1990 May; 122(5):643-50. PubMed ID: 2112817
[TBL] [Abstract][Full Text] [Related]
5. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
[TBL] [Abstract][Full Text] [Related]
6. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
[TBL] [Abstract][Full Text] [Related]
7. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone.
Veldhuis JD; King JC; Urban RJ; Rogol AD; Evans WS; Kolp LA; Johnson ML
J Clin Endocrinol Metab; 1987 Nov; 65(5):929-41. PubMed ID: 3117834
[TBL] [Abstract][Full Text] [Related]
8. Plasma inhibin levels in men with chemotherapy-induced severe damage to the seminiferous epithelium.
Tsatsoulis A; Shalet SM; Robertson WR; Morris ID; Burger HG; De Kretser DM
Clin Endocrinol (Oxf); 1988 Dec; 29(6):659-65. PubMed ID: 3151478
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile bioactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation.
Talbot JA; Rodger RS; Robertson WR
Nephron; 1990; 56(1):66-72. PubMed ID: 2122267
[TBL] [Abstract][Full Text] [Related]
10. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone and follicle stimulating hormone secretion patterns in boys throughout puberty measured using highly sensitive immunoradiometric assays.
Wennink JM; Delemarre-van de Waal HA; Schoemaker R; Schoemaker H; Schoemaker J
Clin Endocrinol (Oxf); 1989 Nov; 31(5):551-64. PubMed ID: 2516786
[TBL] [Abstract][Full Text] [Related]
12. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis.
Mulligan T; Iranmanesh A; Kerzner R; Demers LW; Veldhuis JD
Eur J Endocrinol; 1999 Sep; 141(3):257-66. PubMed ID: 10474123
[TBL] [Abstract][Full Text] [Related]
13. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
14. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
[TBL] [Abstract][Full Text] [Related]
16. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
Veldhuis JD; Rogol AD; Johnson ML
J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
[TBL] [Abstract][Full Text] [Related]
17. Testicular function following the treatment of Hodgkin's disease in childhood.
Shafford EA; Kingston JE; Malpas JS; Plowman PN; Pritchard J; Savage MO; Eden OB
Br J Cancer; 1993 Dec; 68(6):1199-204. PubMed ID: 8260374
[TBL] [Abstract][Full Text] [Related]
18. Gonadal function following chemotherapy for childhood Hodgkin's disease.
Mackie EJ; Radford M; Shalet SM
Med Pediatr Oncol; 1996 Aug; 27(2):74-8. PubMed ID: 8649323
[TBL] [Abstract][Full Text] [Related]
19. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
Gross KM; Matsumoto AM; Southworth MB; Bremner WJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
[TBL] [Abstract][Full Text] [Related]
20. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
van den Berg H; Furstner F; van den Bos C; Behrendt H
Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
